Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Sonnet BioTherapeutics I...

    NASDAQ: SONN · Real-Time Price · USD
    3.49
    -0.27 (-7.18%)
    At close: Aug 15, 2025, 12:54 PM

    Sonnet BioTherapeutics Income Statement

    Financials in USD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
    Revenue
    		 18.63K 147.81K 349.94K 483.63K
    Cost of Revenue
    		 n/a 75.75K 93.26K 95.16K
    Gross Profit
    		 18.63K 147.81K -21.09M 388.46K
    Operating Income
    		 -11.85M -18.79M -29.67M -25.09M
    Interest Income
    		 n/a n/a n/a 15.00
    Pretax Income
    		 -7.44M -18.83M -29.72M -24.98M
    Net Income
    		 -7.44M -18.83M -29.77M -25.01M
    Selling & General & Admin
    		 6.13M 7.13M 8.58M 8.94M
    Research & Development
    		 5.74M 11.81M 21.44M 16.63M
    Other Expenses
    		 n/a n/a -21.44M n/a
    Operating Expenses
    		 11.87M 18.94M 8.58M 25.57M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 11.87M 18.94M 30.02M 25.57M
    Income Tax Expense
    		 n/a n/a 52.48K 22.03K
    Shares Outstanding (Basic)
    		 655.24K 129.77K 24.7K 9.96K
    Shares Outstanding (Diluted)
    		 655.24K 129.77K 24.7K 9.96K
    EPS (Basic)
    		 -11.35 -145.12 -1.2K -2.51K
    EPS (Diluted)
    		 -11.35 -145.12 -1.2K -2.51K
    EBITDA
    		 -11.77M -18.72M -29.58M -24.99M
    EBIT
    		 -11.85M -18.79M -29.67M -25.09M
    Depreciation & Amortization
    		 83.11K 75.75K 93.26K 95.16K

    Add to Watchlist